title: Fibrotic involution of sural muscles secondary to lupus panniculitis.
authors.forename: B
authors.initials: B
authors.lastname: Ferlazzo
authors.forename: E
authors.initials: E
authors.lastname: Ferlazzo
authors.forename: S
authors.initials: S
authors.lastname: Isola
authors.forename: G
authors.initials: G
authors.lastname: Marotta
authors.forename: S
authors.initials: S
authors.lastname: Saitta
authors.forename: L
authors.initials: L
authors.lastname: Ricciardi
mesh_terms: D000328:Adult; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005355:Fibrosis / Q000188:drug therapy / Q000209:etiology / Q000473:pathology*; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use; D007866:Leg / Q000473:pathology; D008279:Magnetic Resonance Imaging; D008297:Male; D018482:Muscle, Skeletal / Q000473:pathology*; D015435:Panniculitis, Lupus Erythematosus / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D011241:Prednisone / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D006886:Hydroxychloroquine; D016572:Cyclosporine; D011241:Prednisone